Alan Rigby is the founder of HiberCell. HiberCell has raised $250M in total funding. Latest round: Series B. Backed by ARCH Venture Partners.
Alan C. Rigby, PhD, is the founder and leader of HiberCell, a New York-based biotechnology company launched in 2019. The company focuses on developing therapeutics that prevent cancer relapse and metastasis by targeting tumor dormancy. Under his leadership, HiberCell raised over $250 million in total funding.
Full founder directory · Investor directory · Company funding database · Fundraising library